Prevalence and risk factors for oral HPV infection in young Australians

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Antonsson, Annika ^a   Cornford, Michelle ^b   Perry, Susan ^a   Davis, Marcia ^a   Dunne, Michael P ^b   Whiteman, David C ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CONTRACEPTIVE AGENT; ILLICIT DRUG; WART VIRUS VACCINE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; AUSTRALIA; AUSTRALIAN; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG MISUSE; ETHNIC GROUP; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 67; HUMAN PAPILLOMAVIRUS TYPE 69; HUMAN PAPILLOMAVIRUS TYPE 90; INFECTION RISK; INTIMACY; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MOUTH INFECTION; NONHUMAN; ORAL SEX; PAPILLOMAVIRUS INFECTION; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SMOKING; UNIVERSITY STUDENT; WART VIRUS; YOUNG ADULT; ADOLESCENT; ALPHAPAPILLOMAVIRUS; CLASSIFICATION; EPIDEMIOLOGY; GENETICS; MOUTH DISEASES; PAPILLOMAVIRUS INFECTIONS; VIROLOGY;

ADOLESCENT; ADULT; ALPHAPAPILLOMAVIRUS; AUSTRALIA; FEMALE; HUMANS; MALE; MOUTH DISEASES; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RISK FACTORS; SEXUAL BEHAVIOR; YOUNG ADULT;

EID: 84898646054     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091761     Document Type: Article

References (26)

1. Attner P, Nasman A, Du J, Hammarstedt L, Ramqvist T, et al. (2012) Survival in patients with human papillomavirus positive tonsillar cancer in relation to treatment. Int J Cancer 131:1124-1130.
2. Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, et al. (2011) Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 29:4294-4301.
3. Nasman A, Attner P, Hammarstedt L, Du J, Eriksson M, et al. (2009) Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer 125:362-366.
4. Gillison ML, D'Souza G, Westra W, Sugar E, Xiao W, et al. (2008) Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-n (Pubitemid 351480511)
5. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, et al. (2000) Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92:709-720. (Pubitemid 30365531)
6. Hong AM, Grulich AE, Jones D, Lee CS, Garland SM, et al. (2010) Squamous cell carcinoma of the oropharynx in Australian males induced by human papillomavirus vaccine targets. Vaccine 28:3269-3272.
7. Du J, Nordfors C, Ahrlund-Richter A, Sobkowiak M, Romanitan M, et al. (2012) Prevalence of oral human papillomavirus infection among youth, Sweden. Emerg Infect Dis 18:1468-1471.
8. D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, et al. (2007) Casecontrol study of human papillomavirus and oropharyngeal cancer. N Engl J Med 356:1944-1956. (Pubitemid 46740304)
9. Kreimer AR, Clifford GM, Boyle P, Franceschi S (2005) Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 14:467-475. (Pubitemid 40270113)
10. Gillison ML, Broutian T, Pickard RK, Tong ZY, Xiao W, et al. (2012) Prevalence of oral HPV infection in the United States, 2009-2010. JAMA 307:693-703.
11. Bottalico D, Chen Z, Dunne A, Ostoloza J, McKinney S, et al. (2011) The oral cavity contains abundant known and novel human papillomaviruses from the Betapapillomavirus and Gammapapillomavirus genera. J Infect Dis 204:787-792.
12. Kurose K, Terai M, Soedarsono N, Rabello D, Nakajima Y, et al. (2004) Low prevalence of HPV infection and its natural history in normal oral mucosa among volunteers on Miyako Island, Japan. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 98:91-96. (Pubitemid 38953837)
13. Nordfors C, Grun N, Haeggblom L, Tertipis N, Sivars L, et al. (2013) Oral human papillomavirus prevalence in high school students of one municipality in Sweden. Scand J Infect Dis.
14. Pickard RK, Xiao W, Broutian TR, He X, Gillison ML (2012) The prevalence and incidence of oral human papillomavirus infection among young men and women, aged 18-30 years. Sex Transm Dis 39:559-566.
15. De Roda Husman AM, Walboomers JM, Van Den Brule AJ, Meijer CJ, Snijders PJ (1995) The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 76:1057-1062.
16. De Roda Husman AM, Walboomers JM, Hopman E, Bleker OP, Helmerhorst TM, et al. (1995) HPV prevalence in cytomorphologically normal cervical scrapes of pregnant women as determined by PCR: the age-related pattern. J Med Virol 46:97-102.
17. Edelstein ZR, Schwartz SM, Hawes S, Hughes JP, Feng Q, et al. (2012) Rates and determinants of oral human papillomavirus infection in young men. Sex Transm Dis 39:860-867.
18. Forslund O, Johansson H, Madsen KG, Kofoed K (2013) The nasal mucosa contains a large spectrum of human papillomavirus types from the Betapapillomavirus and Gammapapillomavirus genera. J Infect Dis 208:1335-1341.
19. Hansson BG, Rosenquist K, Antonsson A, Wennerberg J, Schildt EB, et al. (2005) Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Acta Otolaryngol 125:1337-1344. (Pubitemid 41722001)
20. Kino N, Sata T, Sato Y, Sugase M, Matsukura T (2000) Molecular cloning and nucleotide sequence analysis of a novel human papillomavirus (Type 82) associated with vaginal intraepithelial neoplasia. Clin Diagn Lab Immunol 7:91-95. (Pubitemid 30051468)
21. Kirii Y, Matsukura T (1998) Nucleotide sequence and phylogenetic classification of human papillomavirus type 67. Virus Genes 17:117-121. (Pubitemid 28517622)
22. Terai M, Burk RD (2002) Identification and characterization of 3 novel genital human papillomaviruses by overlapping polymerase chain reaction: candHPV89, candHPV90, and candHPV91. J Infect Dis 185:1794-1797. (Pubitemid 34615475)
23. D'Souza G, Agrawal Y, Halpern J, Bodison S, Gillison ML (2009) Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis 199:1263-1269.
24. Kreimer AR, Villa A, Nyitray AG, Abrahamsen M, Papenfuss M, et al. (2011) The epidemiology of oral HPV infection among a multinational sample of healthy men. Cancer Epidemiol Biomarkers Prev 20:172-182.
25. Beachler DC, Weber KM, Margolick JB, Strickler HD, Cranston RD, et al. (2012) Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults. Cancer Epidemiol Biomarkers Prev 21:122-133.
26. Herrero R, Quint W, Hildesheim A, Gonzalez P, Struijk L, et al. (2013) Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa Rica. PLoS One 8:e68329.